The economic valuation of the opioid treatment sector has seen a steady upward trajectory as addiction is increasingly recognized as a chronic brain disease rather than a moral failing. This medicalization of the issue has opened up new avenues for funding and research. The market size is not just a reflection of the cost of the medication itself, but also the vast infrastructure of...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt